FDA Approved: OXALIPLATIN — Supplemental Application (Winthrop U.S, a business of sanofi-aventis U.S. LLC)

View source ↗

Summary

FDA approved a supplemental application for Oxaliplatin (Eloxatin) to update the product labeling under Winthrop U.S., a business of sanofi-aventis U.S. LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Eloxatin (oxaliplatin)

Snippet

SUPPL AP for OXALIPLATIN (OXALIPLATIN)